The Scientific Team

Benny Evison

Benny Evison - Chief Scientific Officer

BSc (Hons), PhD

Dr Benny Evison completed his B. Sc. (Med. Sci.) (Hons) in 2001 and commenced his PhD studies in 2002 at La Trobe University (LTU), Melbourne, Australia. During his PhD at LTU (2002–2007), he gained extensive research experience in the design, development, and analysis of novel DNA-directed therapeutic agents for the treatment of cancer, particularly breast and prostate cancers and lymphomas. Dr. Evison was appointed as a postdoctoral research fellow in the School of Molecular Sciences, LTU in 2008 where he continued his research in the development of improved anticancer drugs and mentored students at both Honours and PhD levels. He subsequently moved to world-renowned St. Jude Children’s Research Hospital, Memphis, TN, USA, to commence a second postdoctoral research fellowship (2011-2017) where he was involved in the discovery and development of novel inhibitors of DNA repair for the chemo-sensitisation of paediatric cancers to existing DNA damage based therapies.

In 2017, Dr Evison returned to Australia to the post of Director of Pre-clinical (non-oncology) in Noxopharm Ltd with responsibility for that Company’s non-oncology pre-clinical program. That program now has been transferred into US biotechnology company, Nyrada Inc, where Benny hopes to leverage his extensive drug development experience to generate novel therapeutic entities for the treatment of neurodegenerative diseases of humans.

Alexandra Suchowerska

Alexandra Suchowerska - Neuroscience Researcher

B.Sc. (Hons), PhD

Dr. Alexandra Suchowerska will utilize her extensive research experience and work alongside Dr. Benny Evison on the NYX-104 and NYX-205 programs.

Alexandra completed her B.Sc. in 2011 at the University of Sydney majoring in physiology and immunology. In 2012, she achieved First Class Honours in the lab of Prof. Lars Ittner where she gained extensive research experience with various mouse models of Alzheimer’s disease.

In 2013, Dr. Suchowerska moved to the University of New South Wales (UNSW) to commence a Research Assistant position in the lab of A/Prof Thomas Fath. During her PhD at UNSW (2014-2017), Alexandra’s research focused on the connection between nerve cells and how these connections break down early in Alzheimer’s disease pathology. She also expanding her research focus and continues publishing with collaborators working on various neurological disorders. 

In 2017, Alexandra was appointed as a Postdoctoral Research Fellow in the School of Medical Sciences at UNSW, mentoring PhD students in the novel techniques she developed and mastered during her PhD.

Jasneet Parmar

Jasneet Parmar - Neuroscience Researcher  

B. Med Sci (Hons in Pharmacology)

Jasneet Parmar completed her B Med Sci (Hons in Pharmacology) in 2013 at UNSW Sydney, Australia. During her Honours program she studied the influence of hypoxic preconditioning, a neuroprotective therapy, on inflammation, in a model of neonatal brain injury in the lab of Dr. Nicole Jones.

She began her PhD in 2014 at the Translational Neuroscience Facility, Department of Physiology at UNSW Sydney, Australia under the mentorship of Prof Gary Housley. During her candidature she worked extensively on the development of a brain injury model. In parallel she also studied the putative contribution of a calcium permeable ion channel in brain injury as a potential neuroprotective target for cerebellar strokes.

Jasneet joined Nyrada Inc. in 2018 as a Neuroscience Researcher and is working alongside Dr. Benny Evison and Dr. Alexandra Suchowerska on the NYX-104 and NYX-205. With her background in brain injury, she hopes to find new avenues for development of novel drug targets for mitigating brain injury and other neurological deficits.

  Subscribe to Email Alerts